Here, we reported that hepatocyte-specific deficiency of HIF-2α cannot improve CCl4-induced liver fibrosis in mice, and deletion of hepatocyte-specific HIF-2α is not the ideal therapeutic strategy for liver fibrosis. Here, EPAS1 is linked to Hepatic fibrosis.